• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Phosphorylation of the mu-opioid receptor at tyrosine 166 (Tyr3.51) in the DRY motif reduces agonist efficacy.在 DRY 基序中,μ-阿片受体酪氨酸 166(Tyr3.51)的磷酸化降低了激动剂的效能。
Mol Pharmacol. 2010 Mar;77(3):339-47. doi: 10.1124/mol.109.060558. Epub 2009 Dec 3.
2
Tyrosine phosphorylation of the mu-opioid receptor regulates agonist intrinsic efficacy.μ-阿片受体的酪氨酸磷酸化调节激动剂的内在效力。
Mol Pharmacol. 2001 Jun;59(6):1360-8. doi: 10.1124/mol.59.6.1360.
3
Agonist-induced, G protein-dependent and -independent down-regulation of the mu opioid receptor. The receptor is a direct substrate for protein-tyrosine kinase.激动剂诱导的、G蛋白依赖性和非依赖性的μ阿片受体下调。该受体是蛋白酪氨酸激酶的直接底物。
J Biol Chem. 1999 Sep 24;274(39):27610-6. doi: 10.1074/jbc.274.39.27610.
4
Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins.偏向性μ-阿片受体激动剂对受体与其同源G蛋白的侧向移动和功能偶联具有不同的调节作用。
Naunyn Schmiedebergs Arch Pharmacol. 2016 Dec;389(12):1289-1300. doi: 10.1007/s00210-016-1293-8. Epub 2016 Sep 6.
5
Ligand-dependent spatiotemporal signaling profiles of the μ-opioid receptor are controlled by distinct protein-interaction networks.μ 阿片受体配体依赖性时空信号转导谱受不同蛋白相互作用网络调控。
J Biol Chem. 2019 Nov 1;294(44):16198-16213. doi: 10.1074/jbc.RA119.008685. Epub 2019 Sep 12.
6
CB1 receptor-independent actions of SR141716 on G-protein signaling: coapplication with the mu-opioid agonist Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol unmasks novel, pertussis toxin-insensitive opioid signaling in mu-opioid receptor-Chinese hamster ovary cells.SR141716对G蛋白信号传导的CB1受体非依赖性作用:与μ-阿片样物质激动剂Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol共同应用揭示了μ-阿片样物质受体-中国仓鼠卵巢细胞中新型的、对百日咳毒素不敏感的阿片样物质信号传导。
J Pharmacol Exp Ther. 2009 Aug;330(2):567-74. doi: 10.1124/jpet.109.152710. Epub 2009 May 15.
7
Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.长期暴露于μ-阿片受体激动剂会导致μ-阿片受体的组成性激活,其激活程度与用于预处理的激动剂的效力成正比。
Mol Pharmacol. 2001 Jul;60(1):53-62. doi: 10.1124/mol.60.1.53.
8
Mu opioid receptor activation enhances regulator of G protein signaling 4 association with the mu opioid receptor/G protein complex in a GTP-dependent manner.μ阿片受体激活以GTP依赖的方式增强G蛋白信号调节因子4与μ阿片受体/G蛋白复合物的结合。
J Neurochem. 2015 Oct;135(1):76-87. doi: 10.1111/jnc.13222. Epub 2015 Jul 16.
9
Mu opioid receptor mutant, T394A, abolishes opioid-mediated adenylyl cyclase superactivation.μ阿片受体突变体T394A消除了阿片类药物介导的腺苷酸环化酶超激活。
Neuroreport. 2007 Dec 3;18(18):1969-73. doi: 10.1097/WNR.0b013e3282f228b2.
10
Lack of mu-opioid receptor-mediated G-protein activation in the spinal cord of mice lacking Exon 1 or Exons 2 and 3 of the MOR-1 gene.在缺乏MOR-1基因外显子1或外显子2和3的小鼠脊髓中,μ-阿片受体介导的G蛋白激活缺失。
J Pharmacol Sci. 2003 Dec;93(4):423-9. doi: 10.1254/jphs.93.423.

引用本文的文献

1
Trace amine associated receptor 1: predicted effects of single nucleotide variants on structure-function in geographically diverse populations.痕量胺相关受体 1:单核苷酸变异对地理分布不同人群结构-功能的预测影响。
Hum Genomics. 2024 Jun 11;18(1):61. doi: 10.1186/s40246-024-00620-w.
2
Repurposing EGFR Inhibitors for Oral Cancer Pain and Opioid Tolerance.将表皮生长因子受体(EGFR)抑制剂用于口腔癌疼痛及阿片类药物耐受性的新用途研究
Pharmaceuticals (Basel). 2023 Nov 3;16(11):1558. doi: 10.3390/ph16111558.
3
Additive Anticonvulsant Profile and Molecular Docking Analysis of 5,5'-Diphenylhydantoin Schiff Bases and Phenytoin.5,5'-二苯基乙内酰脲席夫碱和苯妥英的相加抗惊厥作用及分子对接分析
Biomedicines. 2023 Oct 27;11(11):2912. doi: 10.3390/biomedicines11112912.
4
Mu-opioid receptor and receptor tyrosine kinase crosstalk: Implications in mechanisms of opioid tolerance, reduced analgesia to neuropathic pain, dependence, and reward.μ-阿片受体与受体酪氨酸激酶的相互作用:对阿片类药物耐受性、神经性疼痛镇痛效果降低、依赖性和奖赏机制的影响。
Front Syst Neurosci. 2022 Dec 1;16:1059089. doi: 10.3389/fnsys.2022.1059089. eCollection 2022.
5
Quantitative Systems Pharmacology and Biased Agonism at Opioid Receptors: A Potential Avenue for Improved Analgesics.定量系统药理学与阿片受体的偏性激动作用:改善镇痛药的潜在途径。
Int J Mol Sci. 2022 May 4;23(9):5114. doi: 10.3390/ijms23095114.
6
Molecular mechanisms of opioid tolerance: From opioid receptors to inflammatory mediators (Review).阿片类药物耐受性的分子机制:从阿片受体到炎症介质(综述)
Exp Ther Med. 2021 Sep;22(3):1004. doi: 10.3892/etm.2021.10437. Epub 2021 Jul 15.
7
Modulation of Pathological Pain by Epidermal Growth Factor Receptor.表皮生长因子受体对病理性疼痛的调节作用
Front Pharmacol. 2021 May 12;12:642820. doi: 10.3389/fphar.2021.642820. eCollection 2021.
8
Relevance of Mu-Opioid Receptor Splice Variants and Plasticity of Their Signaling Sequelae to Opioid Analgesic Tolerance.μ-阿片受体剪接变体及其信号后遗症的可塑性与阿片类镇痛耐受性的相关性
Cell Mol Neurobiol. 2021 Jul;41(5):855-862. doi: 10.1007/s10571-020-00934-y. Epub 2020 Aug 17.
9
Spinal Opioid Tolerance Depends upon Platelet-Derived Growth Factor Receptor- Signaling, Not -Opioid Receptor Internalization.脊髓阿片类药物耐受取决于血小板衍生生长因子受体信号,而不是阿片受体内化。
Mol Pharmacol. 2020 Oct;98(4):487-496. doi: 10.1124/mol.120.119552. Epub 2020 Jul 28.
10
EGFR Signaling Causes Morphine Tolerance and Mechanical Sensitization in Rats.EGFR 信号转导导致大鼠吗啡耐受和机械性敏化。
eNeuro. 2020 Apr 6;7(2). doi: 10.1523/ENEURO.0460-18.2020. Print 2020 Mar/Apr.

本文引用的文献

1
Src phosphorylation of micro-receptor is responsible for the receptor switching from an inhibitory to a stimulatory signal.微受体的Src磷酸化负责受体从抑制性信号向刺激性信号的转换。
J Biol Chem. 2009 Jan 23;284(4):1990-2000. doi: 10.1074/jbc.M807971200. Epub 2008 Nov 24.
2
Disease-causing mutation in GPR54 reveals the importance of the second intracellular loop for class A G-protein-coupled receptor function.GPR54基因中的致病突变揭示了A类G蛋白偶联受体功能中第二个细胞内环的重要性。
J Biol Chem. 2008 Nov 7;283(45):31068-78. doi: 10.1074/jbc.M805251200. Epub 2008 Sep 4.
3
Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.激动剂诱导的牛视紫红质构象变化:深入了解G蛋白偶联受体的激活
J Mol Biol. 2008 Oct 3;382(2):539-55. doi: 10.1016/j.jmb.2008.06.084. Epub 2008 Jul 7.
4
EGF transregulates opioid receptors through EGFR-mediated GRK2 phosphorylation and activation.表皮生长因子(EGF)通过表皮生长因子受体(EGFR)介导的G蛋白偶联受体激酶2(GRK2)磷酸化和激活来反式调节阿片受体。
Mol Biol Cell. 2008 Jul;19(7):2973-83. doi: 10.1091/mbc.e07-10-1058. Epub 2008 May 7.
5
Agonist-specific regulation of mu-opioid receptor desensitization and recovery from desensitization.μ-阿片受体脱敏及脱敏恢复的激动剂特异性调节
Mol Pharmacol. 2008 Apr;73(4):1301-8. doi: 10.1124/mol.107.042952. Epub 2008 Jan 15.
6
Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation.人β₂肾上腺素能受体的配体稳定构象状态:对G蛋白偶联受体激活的深入了解。
Biophys J. 2008 Mar 15;94(6):2027-42. doi: 10.1529/biophysj.107.117648. Epub 2007 Dec 7.
7
GPCR-jacking: from a new route in RTK signalling to a new concept in GPCR activation.G蛋白偶联受体劫持:从受体酪氨酸激酶信号传导的新途径到G蛋白偶联受体激活的新概念
Trends Pharmacol Sci. 2007 Dec;28(12):602-7. doi: 10.1016/j.tips.2007.09.007. Epub 2007 Nov 14.
8
Beta-arrestin2 and c-Src regulate the constitutive activity and recycling of mu opioid receptors in dorsal root ganglion neurons.β-抑制蛋白2和c-Src调节背根神经节神经元中μ阿片受体的组成性活性和再循环。
J Neurosci. 2007 May 9;27(19):5092-104. doi: 10.1523/JNEUROSCI.1157-07.2007.
9
The absence of endogenous beta-endorphin selectively blocks phosphorylation and desensitization of mu opioid receptors following partial sciatic nerve ligation.内源性β-内啡肽的缺失选择性地阻断了坐骨神经部分结扎后μ阿片受体的磷酸化和脱敏。
Neuroscience. 2007 Jun 8;146(4):1795-807. doi: 10.1016/j.neuroscience.2007.03.029. Epub 2007 Apr 30.
10
Receptor-mediated activation of heterotrimeric G-proteins: current structural insights.受体介导的异源三聚体G蛋白激活:当前的结构见解
Mol Pharmacol. 2007 Aug;72(2):219-30. doi: 10.1124/mol.107.034348. Epub 2007 Apr 12.

在 DRY 基序中,μ-阿片受体酪氨酸 166(Tyr3.51)的磷酸化降低了激动剂的效能。

Phosphorylation of the mu-opioid receptor at tyrosine 166 (Tyr3.51) in the DRY motif reduces agonist efficacy.

机构信息

Department of Pharmacology, University of Washington School of Medicine, Seattle, WA 98195-7280, USA.

出版信息

Mol Pharmacol. 2010 Mar;77(3):339-47. doi: 10.1124/mol.109.060558. Epub 2009 Dec 3.

DOI:10.1124/mol.109.060558
PMID:19959593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2835424/
Abstract

The effects of phosphorylation of the tyrosine residue in the highly conserved DRY motif expressed in the putative second cytoplasmic loop of the mu-opioid receptor were assessed after expression in human embryonic kidney (HEK) 293 cells. Tyrosine kinase activation by epidermal growth factor (EGF) or hydrogen peroxide treatment effectively increased phosphorylation of the tyrosine-166 in the mu-opioid receptor (MOR-Tyr166p) as measured by a novel phosphoselective antibody. We were surprised to find that the increase in MOR-Tyr166p immunoreactivity (ir) required coactivation by the opioid agonist [D-Ala(2),methyl-Phe(4),Gly(5)-ol]enkephalin (DAMGO), as demonstrated by both Western blot imaging of membrane proteins and confocal microscopy of transfected cells; MOR-Tyr166p-ir did not significantly increase after either DAMGO, EGF, or H(2)O(2) treatment alone. The increase in MOR-Tyr166p-ir was blocked by pretreatment with the opioid antagonist naloxone or the Src kinase inhibitor 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine. Consistent with these data, mutation of the tyrosine-166 to phenylalanine blocked the increased immunoreactivity, and untransfected HEK293 cells did not increase MOR-Tyr166p-ir after treatment. DAMGO increased guanosine 5'-O-(3-[(35)S]thio)triphosphate ([(35)S]GTP gamma S) binding to membranes from cells expressing wild-type MOR or MOR-Y166F receptors in a dose-dependent manner. Pretreatment of the wild-type MOR-expressing cells with the combination of DAMGO and EGF completely blocked subsequent DAMGO stimulation of [(35)S]GTP gamma S binding membranes, whereas [(35)S]GTP gamma S binding to membranes from cells expressing mutated MOR(Y166F) was only partially inhibited. These results suggest that G-protein activation as measured by [(35)S]GTP gamma S binding can be regulated by DAMGO and EGF by convergent mechanisms and support the hypothesis that tyrosine phosphorylation within the DRY motif may reduce mu-opioid receptor-G-protein coupling efficiency.

摘要

在人胚肾 (HEK) 293 细胞中表达后,评估了在假定的 μ-阿片受体第二细胞内环中表达的高度保守 DRY 基序中的酪氨酸残基磷酸化的作用。表皮生长因子 (EGF) 或过氧化氢处理的酪氨酸激酶激活可有效增加 μ-阿片受体 (MOR-Tyr166p) 中酪氨酸-166 的磷酸化,如新型磷酸选择性抗体所测量的那样。我们惊讶地发现,MOR-Tyr166p 免疫反应性 (ir) 的增加需要阿片样激动剂 [D-Ala(2),甲基-Phe(4),Gly(5)-ol]enkephalin (DAMGO) 的共激活,这通过膜蛋白的 Western blot 成像和转染细胞的共聚焦显微镜都得到了证明;MOR-Tyr166p-ir 单独用 DAMGO、EGF 或 H(2)O(2) 处理后并未显著增加。MOR-Tyr166p-ir 的增加被阿片拮抗剂纳洛酮或 Src 激酶抑制剂 4-氨基-5-(4-氯-苯基)-7-(叔丁基)吡唑并[3,4-d]嘧啶预处理所阻断。与这些数据一致,将酪氨酸-166 突变为苯丙氨酸可阻断增加的免疫反应性,并且未转染的 HEK293 细胞在用药物处理后不会增加 MOR-Tyr166p-ir。DAMGO 以剂量依赖的方式增加表达野生型 MOR 或 MOR-Y166F 受体的细胞的膜结合鸟苷 5'-O-(3-[(35)S]硫代)三磷酸 ([(35)S]GTPγS)。用 DAMGO 和 EGF 的组合预处理表达野生型 MOR 的细胞完全阻断了随后 DAMGO 对 [(35)S]GTPγS 结合膜的刺激,而表达突变型 MOR(Y166F)的细胞的 [(35)S]GTPγS 结合膜仅部分被抑制。这些结果表明,如 [(35)S]GTPγS 结合所测量的 G 蛋白激活可以通过 DAMGO 和 EGF 通过会聚机制进行调节,并支持这样的假设,即在 DRY 基序内的酪氨酸磷酸化可能会降低 μ-阿片受体-G 蛋白偶联效率。